These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25385173)

  • 1. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
    Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.
    Takahashi Y; Satoh M; Minami Y; Tabuchi T; Itoh T; Nakamura M
    Clin Sci (Lond); 2010 Jul; 119(9):395-405. PubMed ID: 20524934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Immunobiology; 2012 May; 217(5):533-9. PubMed ID: 21899916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
    Tabuchi T; Satoh M; Itoh T; Nakamura M
    Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease.
    Minami Y; Satoh M; Maesawa C; Takahashi Y; Tabuchi T; Itoh T; Nakamura M
    Eur J Clin Invest; 2009 May; 39(5):359-67. PubMed ID: 19371267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.
    Dong J; Liang YZ; Zhang J; Wu LJ; Wang S; Hua Q; Yan YX
    J Atheroscler Thromb; 2017 Apr; 24(4):430-441. PubMed ID: 27629254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease.
    Singh JP; Kulik A; Levin R; Ellinor PT; Ruskin J; Avorn J; Choudhry NK
    Europace; 2012 Sep; 14(9):1287-93. PubMed ID: 22539600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aerobic exercise on miRNA-TLR4 signaling in atherosclerosis.
    Wu XD; Zeng K; Liu WL; Gao YG; Gong CS; Zhang CX; Chen YQ
    Int J Sports Med; 2014 Apr; 35(4):344-50. PubMed ID: 24022569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analysis of microRNA expression profiling for coronary artery disease.
    Li K; Zhang T; Fan H; Li Q; Ito W; Torzewski J; Guo J; Liu Z
    Cardiology; 2014; 127(1):62-9. PubMed ID: 24247647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure.
    Sorbets E; Labreuche J; Simon T; Delorme L; Danchin N; Amarenco P; Goto S; Meune C; Eagle KA; Bhatt DL; Steg PG
    Eur Heart J; 2014 Jul; 35(26):1760-8. PubMed ID: 24616336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renin-angiotensin blockers/inhibitors and statins on mortality and functional impairment in polypathological patients.
    Galindo-Ocaña J; Bernabeu-Wittel M; Formiga F; Fuertes-Martín A; Barón-Franco B; Murcia-Zaragoza JM; Moreno-Gaviño L; Ollero-Baturone M;
    Eur J Intern Med; 2012 Mar; 23(2):179-84. PubMed ID: 22284251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.
    Dickinson BA; Semus HM; Montgomery RL; Stack C; Latimer PA; Lewton SM; Lynch JM; Hullinger TG; Seto AG; van Rooij E
    Eur J Heart Fail; 2013 Jun; 15(6):650-9. PubMed ID: 23388090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
    DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
    Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
    Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
    J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
    Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
    PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study.
    Wu J; Lu C; Diao N; Zhang S; Wang S; Wang F; Gao Y; Chen J; Shao L; Lu J; Zhang X; Weng X; Wang H; Zhang W; Huang Y
    Hum Immunol; 2012 Jan; 73(1):31-7. PubMed ID: 22037148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.